Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019

    NEXT STORY
    Spring Bank Announces Positive Results from the Recently Completed Phase 2 Chronic Hepatitis B ACHIEVE Trial and Additional Inarigivir Studies
    PREV STORY
    DEINOVE invited to present at the 29th congress of the European Society of Clinical Microbiology and Infectious Diseases
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    pSivida Submits New Drug Application (NDA) for Durasert™ Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA

    WATERTOWN, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader ...

    author_avatar
    NASDAQ Market News

    NewLink Genetics to Participate in Upcoming Investor Conferences

    AMES, Iowa, May 08, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that ...

    author_avatar
    NASDAQ Market News

    Immunocore Announces Pricing of Upsized Initial Public Offering

    author_avatar
    NASDAQ Market News